This compound is a synthetic peptide similar to human angiotensin III, provided as an acetate salt and used as an active pharmaceutical ingredient in formulations for managing low blood pressure associated with septic shock. Its structure includes multiple amide bonds, aromatic rings, and a heterocyclic group, reflecting its peptide nature.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 100900-06-9
Angiotensin II
pharmaceutical raw material
Angiotensin I human acetate salt hydrate
research compound
Angiotensin I
pharmaceutical raw material
Angiotensin acetate
research peptide hormone
Daclatasvir
pharmaceutical raw material
Daclatasvir dihydrochloride
pharmaceutical raw material
Vistusertib
pharmaceutical raw material
Levofloxacin
pharmaceutical raw material
acetic acid;(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid
DNYUGSNUNZSLJA-BZDVFTEGSA-N
CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)N.CC(=O)O